Grace Therapeutics Inc. – Filings and Transcripts

NASDAQ: GRCE
Share price (9/30/26): $2.15
Market cap (9/30/26): $45.2 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q1

ended 03/31/26 FY 2026

ended 12/31/25 Q3

ended 09/30/25 Q2 2026 – amended

ended 09/30/25 Q2

Prospectuses and Registrations Filter

Shelf registration

Exempt offering of securities

Shelf registration

Exempt offering of securities

Registration of securities for employees

Ownership Filter

Opaleye Management Inc.

Neugeboren Edward

Kottayil George

News Filter

Shareholder Vote Results

Announces First Quarter 2027 Financial Results, Provides Business Update

Announces $10 Million Private Placement

Announces Receipt of Type a Meeting Minutes From U.S. Food and Drug Administration

Investor Presentation

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness